Literature DB >> 3998920

Chronic benzoate therapy in a boy with partial ornithine transcarbamylase deficiency.

J Letarte, I A Qureshi, R Ouellet, M Godard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3998920     DOI： 10.1016/s0022-3476(85)80359-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.

Authors:  B A Barshop; J Breuer; J Holm; J Leslie; W L Nyhan
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Ornithine transcarbamylase deficiency in a male: strict correlation between metabolic control and plasma arginine concentration.

Authors:  U Wendel; J Wieland; H J Bremer; C Bachmann
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

Review 3.  Alternative pathway therapy for urea cycle disorders.

Authors:  F Feillet; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

4.  Late onset ornithine carbamoyl transferase deficiency in males.

Authors:  E Drogari; J V Leonard
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

5.  Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.